Literature DB >> 25663982

Differential expression of glycoprotein non-metastatic melanoma protein B (GPNMB) involved in trichostatin A-induced apoptosis in gastric cancer.

Wei-Min Ruan1, Yun-Long Li1, Gang Nie1, Wen-Xue Zhou1, Xiao-Ming Zou1.   

Abstract

In this study, we investigated the effect of trichostatin A (TSA) on the gastric cancer cell line BGC-823. The effect of TSA on growth inhibition and apoptosis of BGC-823 cells was examined. The gene expression profile was determined by microarray. Western blotting was used to study the levels of acetylated histone H4 and Glycoprotein non-metastatic melanoma protein B (GPNMB) proteins. GPNMB gene expression was measured by real-time PCR. GPNMB protein levels in gastric adenocarcinoma tissues and adjoining normal tissues were detected by immunohistochemistry. The results showed that a significant decrease in cell population following treatment with 75 ng/mL TSA for 48 h (0.87 ± 0.04) as compared to control (1.14 ± 0.06) (P = 0.02). Apoptotic cells were increased in TSA (75 ng/mL for 48 h) treated group as compared to the control group (from 2.02% to 19.74%) by flow cytometry. The expression of acetylated histone H4 was increased in TSA treated (75 ng/mL for 48 h) group (from 1.00 ± 0.26 to 1.87 ± 0.33, F = 5.862, P = 0.0038) as compared to the control group by Western blotting. After 48 h TSA treatment (75 ng/mL), BGC-823 cells showed decrease in GPNMB gene expression (from 1.00 ± 0.21 to 0.59 ± 0.11, F = 6.214, P = 0.0018). Immunohistochemistry showed that GPNMB expression in gastric adenocarcinoma was significantly higher than the adjoining normal tissues (P = 0.000). To conclusion, our results support that TSA can induce apoptosis, and increase acetylated histone H4 in BGC-823 cells. GPNMB expression is decreased in BGC-823 cells after TSA treatment. GPNMB is overexpressed in gastric adenocarcinoma tissue. GPNMB involved in TSA-induced apoptosis might participate in gastric cancer.

Entities:  

Keywords:  BGC-823; GPNMB; Trichostatin A; apoptosis; histone H4

Year:  2014        PMID: 25663982      PMCID: PMC4307429     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  36 in total

1.  Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P.

Authors:  Persis S Bandari; Jing Qian; Ghassan Yehia; Deval D Joshi; Paul B Maloof; Julius Potian; Hyun S Oh; Pedro Gascon; Jonathan S Harrison; Pranela Rameshwar
Journal:  Regul Pept       Date:  2003-03-28

2.  Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency.

Authors:  Yuliang Tan; Yong Xue; Chunying Song; Michael Grunstein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

Review 3.  Histone acetylation in chromatin structure and transcription.

Authors:  M Grunstein
Journal:  Nature       Date:  1997-09-25       Impact factor: 49.962

4.  Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells.

Authors:  Ewa Jasek; Grzegorz J Lis; Malgorzata Jasinska; Halina Jurkowska; Jan A Litwin
Journal:  Anticancer Res       Date:  2012-07       Impact factor: 2.480

5.  Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.

Authors:  Toshihiko Hoashi; Shinichi Sato; Yuji Yamaguchi; Thierry Passeron; Kunihiko Tamaki; Vincent J Hearing
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

6.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  Gastric cancer cell lines induced by trichostatin A.

Authors:  Xiao-Ming Zou; Yun-Long Li; Hao Wang; Wu Cui; Xiao-Lin Li; Song-Bin Fu; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

9.  Novel genes associated with colorectal cancer are revealed by high resolution cytogenetic analysis in a patient specific manner.

Authors:  Hisham Eldai; Sathish Periyasamy; Saeed Al Qarni; Maha Al Rodayyan; Sabeena Muhammed Mustafa; Ahmad Deeb; Ebthehal Al Sheikh; Mohammed Afzal; Mohammed Afzal Khan; Mishal Johani; Zeyad Yousef; Mohammad Azhar Aziz
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

10.  Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.

Authors:  Gordana Maric; April An Rose; Matthew G Annis; Peter M Siegel
Journal:  Onco Targets Ther       Date:  2013-07-09       Impact factor: 4.147

View more
  5 in total

Review 1.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

2.  Effects of Luteolin on Human Breast Cancer Using Gene Expression Array: Inferring Novel Genes.

Authors:  Shih-Ho Wang; Chin-Hu Wu; Chin-Chuan Tsai; Tai-Yu Chen; Kuen-Jang Tsai; Chao-Ming Hung; Chia-Yi Hsu; Chia-Wei Wu; Tsung-Hua Hsieh
Journal:  Curr Issues Mol Biol       Date:  2022-05-09       Impact factor: 2.976

3.  Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

4.  Trichostatin A potentiates genistein-induced apoptosis and reverses EMT in HEp2 cells.

Authors:  Ruixia Du; Zhe Liu; Xuedong Hou; Gongbi Fu; Ning An; Liping Wang
Journal:  Mol Med Rep       Date:  2016-04-28       Impact factor: 2.952

5.  Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer.

Authors:  Jesse Yu Tajima; Manabu Futamura; Siqin Gaowa; Ryutaro Mori; Toshiyuki Tanahashi; Yoshihiro Tanaka; Nobuhisa Matsuhashi; Takao Takahashi; Kazuya Yamaguchi; Tatsuhiko Miyazaki; Kazuhiro Yoshida
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.